Pediatric burn victims' recovery, diabetes, metabolism aided by fenofibrate (Tricor)

ients," 12:30 p.m.-3 p.m. Sunday April 3, Physiology 361.2/board #A317. On view 7:30 a.m. - 4 p.m.

Cree is presenting the research at the 35th Congress of the International Union of Physiological Sciences in San Diego, March 31 - April 5, 2005.

The entire research team includes: Melanie Green Cree, Alse Aarsland, David Chinkes, David N. Herndon and Robert R. Wolfe from the University of Texas Medical Branch and Shriners Hospital for Children, Galveston.

Surprising 70% of serious burn victims show high insulin resistance

Working with children at the Shriners Hospital for Children, Galveston, the team found that when the children were admitted, "a surprising 70% of children with greater than a 40% total body surface area flame burns have an insulin sensitivity almost half that of healthy children. We wanted to understand why this diabetes develops and to see if medication could reduce it," Cree said.

The study involved 18 child burn victims ages 4 to 14 years of age who were admitted within four days of injury to the Shriners tertiary burn center in Galveston. They were studied four days after their first and third excision and grafting surgeries. The patients were randomly assigned either to placebo or fenofibrate treatment after the first procedure. The fenofibrate (FEN) patients received 5mg/kg of fenofibrate once daily for 112 days. Whole body insulin sensitivity was measured with a clamp technique; stable isotopes of glucose were used to measure liver glucose release and leg glucose uptake was calculated from arterial and venous samples. "Both the liver and the muscle in the leg were examined to try to understand which organs were responsible for the changes in insulin sensitivity, Cree explained.

After treatment, there was no change in the placebo group, but whole body glucose uptake during the clamp, the measure of insulin sensitivity, improved in the FEN group (p = 0.02). Insulin should prevent gluco


Page: 1 2 3 4

Related biology news :

1. Pediatric ritalin use may affect developing brain, new study suggests
2. Pediatric cancer stem cell identified: understanding the origin of ERMS
3. Pediatrics study shows no link between juice and childrens weight
4. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
5. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting
6. VIASYS Healthcare Neonatal Pediatric Fellowship Award
7. Pediatric center to offer novel rehabilitation approach for spinal cord injury
8. Pediatricians lack confidence in managing obesity, and their own weight might be an important factor
9. Pediatric cardiology researchers describe findings in neurologic outcomes, heart devices
10. No sign that ethnic groups genes cause diabetes, international research team says
11. Structure of enzyme offers treatment clues for diabetes, Alzheimers

Post Your Comments:

(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% and reduces ... Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict best advertising ...
(Date:11/9/2019)... ... November 08, 2019 , ... SiteSeer Technologies, creator of ... as a new client and user of SiteSeer. The boutique real estate developer of ... U.S. will use SiteSeer to supplement its own analysis of markets. , Geoffrey ...
(Date:11/6/2019)... ... November 06, 2019 , ... In October, Massachusetts stem cell ... patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem ... the treating stem cells. This problem affects all patients receiving stem cell ...
Breaking Biology News(10 mins):
(Date:11/19/2019)... ... November 19, 2019 , ... Supercomputing Conference ... learning infrastructure solutions for Autonomous Vehicle , Medical Imaging, and Natural Language ... systems with the Graphcore Poplar® software stack as part of its bare-metal cloud ...
(Date:11/12/2019)... ... November 12, 2019 , ... Genedata, ... that Immatics Biotechnologies , a clinical-stage biopharmaceutical company developing T-cell receptor ... R&D operations related to the discovery and development of high-affinity and high-specificity ...
(Date:11/12/2019)... Va. (PRWEB) , ... November 12, 2019 , ... ... forensic DNA services, welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, ... Genealogy Service (FGS) to ultimately provide investigative leads to law enforcement through ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... for use in pathology research, today announced the results of analyses examining ... enrolled in the phase 3 selonsertib studies (STELLAR). Strong correlations were demonstrated ...
Breaking Biology Technology:
Cached News: